Idra stock price target

Idera Pharmaceuticals Inc. - NASDAQ:IDRA - Stock Quote ... View detailed financial information, real-time news, videos, quotes and analysis on Idera Pharmaceuticals Inc. (NASDAQ:IDRA). Explore commentary on Idera Pharmaceuticals Inc. and hear what the

IDRA - Research and Analysis for IDERA PHARMACEUTICALS ... In-depth view of key statistics and finances for IDERA PHARMACEUTICALS, INC. (IDRA) on MSN Money. Idera Pharmaceuticals: Strong Pipeline, Strong ... Jul 24, 2018 · Idera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the treatment of cancer (and formerly rare diseases).Idera's stock … Idera Pharmaceuticals Analysts | Markets Insider PRICE TARGET No. of Brokers 5 Median Target 8.200 USD Highest Target 10.000 USD Lowest Target 5.000 USD Analyst Opinions for Idera Pharmaceuticals Inc Registered Shs Stock quotes by finanzen Idera Pharmaceuticals, Inc. (IDRA) Stock Price, Quote ...

Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 10.00 

View detailed financial information, real-time news, videos, quotes and analysis on Idera Pharmaceuticals Inc. (NASDAQ:IDRA). Explore commentary on Idera Pharmaceuticals Inc. and hear what the IDRA Idera Pharmaceuticals, Inc. Stock Quote Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology in the United States. It offers Tilsotolimod, a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors Idera Pharmaceuticals Inc (NASDAQ:IDRA) Expected to Post ...

Get the latest Idera Pharmaceuticals, Inc. (IDRA) stock news and headlines to help you in your trading and investing decisions. 1y Target Est: N/A: Fair Value is the appropriate price for the

The IDRA stock was last observed hovering at around $1.63 in the last trading session, with the day’s loss setting it -0.04% off its average median price target of $9.00 for the next 12 months. It is also 84.1% off the consensus price target high of $10.00 offered by 6 analysts, but current levels are 77.29% higher than the price target low IDRA Stock Price and Chart — NASDAQ:IDRA — TradingView IDRA on watch for this week. Although the last candle is bearish engulfing this could mean an opportunity to enter at a lower price point. It did however manage to close over the 200/50/10 moving averages ADX is over 28 DMI+ is over 30 DMI- is at 16 I am looking to enter this at around 1.85 to 1.9 for a swing.

Mar 27, 2020 · IDRA's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low

Stock quote for Idera Pharmaceuticals, Inc. Common Stock Common Stock (IDRA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. IDRA Stock Price & Charts | Idera Pharmaceuticals In depth view into IDRA (Idera Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.

Idera Pharmaceuticals, Inc. (IDRA) Latest Stock News ...

Idera Pharmaceuticals stock price target cut to $7 from $16 at Wedbush MarketWatch. Tuesday, July 10, 2018. 04:36 PM ET. BioCryst's stock jumps, Idera drops as proposed merger called off MarketWatch. Tuesday, June 12, 2018. 07:42 AM ET. Idera Pharmaceuticals' stock plummets after phase 2 trial failure of dermatomyositis treatment MarketWatch Idera Pharmaceuticals, Inc. Common Stock (IDRA) Real-Time ... Mar 27, 2020 · IDRA's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low IDRA Stock Quote - Idera Pharmaceuticals, Inc. Common ... Stock quote for Idera Pharmaceuticals, Inc. Common Stock Common Stock (IDRA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. IDRA Stock Price & Charts | Idera Pharmaceuticals

Idera Pharmaceuticals, Inc. (“Idera” or “the company”) (IDRA) today announced completion of patient enrollment into ILLUMINATE-301, its registrational trial of tilsotolimod in combination with ipilimumab in patients with anti-PD-1 refractory advanced melanoma. IDRA - Idera Pharmaceuticals, Inc. Summary, Stock Quote ...